Pneumomediastinum following immunization of BioNTech COVID-19 vaccine: A coincidence? by Shen-Hao Lai, Sui-Ling Liao

“…Background: To build immunity against the pandemic severe acute respiratory syndrome coronavirus-2 infection in adolescents, wide-ranging immunization with BioNTech (BNT) vaccine was initiated in September 2021 in Taiwan. …”
Get full text

Delayed-onset anaphylaxis after first dose of Pfizer-BioNTech COVID-19 vaccine by Carol Tay, Damien Lai

Get full text

Side effects of the Pfizer BioNTech vaccine in health workers of a hospital in the southeast of Mexico by Jesús Arturo Ruiz-Quiñones, Víctor Manuel Narváez-Osorio, Oscar Antonio Ulín-Tejeda, Oscar Israel Flores-Barrientos, Samuel Suárez-Méndez, Guadalupe del Carmen Baeza-Flores

“… Introduction: The goal of this study was to evaluate the side effects of application of the Pfizer BioNTech vaccine on the workers at a Mexican hospital. …”
Get full text

Good news reduces trust in government and its efficacy: The case of the Pfizer/BioNTech vaccine announcement. by Shaun P Hargreaves Heap, Christel Koop, Konstantinos Matakos, Aslı Unan, Nina Weber

“…The announcement of Pfizer/BioNTech's COVID-19 vaccine success on November 9, 2020 led to a global stock market surge. …”
Get full text

Chronic Spontaneous Urticaria Following Pfizer-BioNTech Coronavirus Disease 2019 Messenger RNA Vaccination by Michael J. Adame, Nicole A. Christians, Aisha Q. Mohammed, Julia W. Tripple

“…In this case, we describe a 35-year-old woman who was newly diagnosed with CSU after receiving the Pfizer-BioNTech COVID-19 mRNA vaccine.…”
Get full text

Minimal Change Nephrotic Syndrome with Acute Kidney Injury after the Administration of Pfizer-BioNTech COVID-19 Vaccine by Erdinc Gulumsek, Dilan Damla Ozturk, Huseyin Ali Ozturk, Tayyibe Saler, Kivilcim Eren Erdogan, Ahmed Muhammad Bashir, Hilmi Erdem Sumbul

“…This study examines a case of nephrotic syndrome with acute renal injury after Pfizer-BioNTech vaccine.…”
Get full text

Delirium as an Adverse Reaction to BNT162b2 mRNA Vaccine from Pfizer Inc., and BioNTech by Lilia M. Sierra Galan, Raquel Cohen Shaooli

“…We present a 76-year-old male patient who developed delirium after receiving the second dose of the BNT162b2 mRNA vaccine from Pfizer Inc. and BioNTech®. We theorize about the potential pathophysiology mechanisms involved.…”
Get full text

New-onset bullous pemphigoid following the fifth dose of the COVID-19 vaccine Pfizer-BioNTech: A case report by Eman Badawod

“…This report presents a case of a 54-year-old male in Canada who developed new-onset bullous pemphigoid 4 weeks after receiving his fifth COVID-19 vaccine booster (Pfizer-BioNTech). The patient initially presented with a generalized erythematous rash, which progressed despite treatment with topical and systemic corticosteroids. …”
Get full text

Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report by Shungo Yano, Taiju Miyagami, Takayuki Furusaka, Nagamasa Kano, Toshio Naito

Get full text

Eventos adversos por la vacuna COVID-19 Pfizer-BioNTech® en niños de 5-17años by María del Rocío Hernández-Morales, Margarita Aguirre Barbosa, Mancilla Hernández, Sandra Aidée González Hidalgo, Estefanía Alavez López, Sandra Maldonado Castañeda

Subjects: Get full text

Comparison of IgG and Neutralizing Antibody Response After Pfizer BioNTech COVID-19 Vaccine Among Iraqi Individuals by Najat Saeed Hussein, Izzat Abdulsatar Al-Rayahi, Salwa S. Muhsin, Redhwan Abdul Kareem Alameer

“…A total of 41 vaccinated individuals with Pfizer-BioNTech COVID-19 vaccine, as well as (10) non vaccinated were included in the study.   …”
Get full text

Relapse of Evans syndrome following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine: case report and literature review by Mirjana Cvetković, Nikola Pantić, Marijana Virijević, Zlatko Pravdić, Nikica Sabljić, Mirjana Mitrović, Nada Suvajdžić-Vuković

“…In May 2021, eight days after the second dose of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine, he experienced mucocutaneous bleeding. …”
Get full text

Trigeminal neuralgia occurring after the third dose of Pfizer BioNTech COVID-19 vaccine. Complication or coincidence?... by Kacper Chrostowski, Michał Piasecki, Joanna Bielewicz

“…The pain appeared two months ago, on the day following the vaccination using the third dose of the Pfizer BioNTech COVID-19 vaccine. At the Neurology Department she was diagnosed with trigeminal neuralgia. …”
Get full text

False positive results in the Widal test in adults immunized with the Commirnaty (Pfizer-BioNtech) and BBIBP-CorV (Sinopharm) vaccines against COVID-19 by Jeel Moya-Salazar, Lizbeth Y. Ciprian, Víctor Rojas-Zumaran, Belén Moya-Salazar, Belén Moya-Salazar, Eliane A. Goicochea-Palomino, Hans Contreras-Pulache

“…The Widal test for the detection of typhoid fever is an antigen–antibody test that can be affected by vaccination, causing errors in the results, so we determined the frequency of false positive results of the Widal test in adults vaccinated with Commirnaty (Pfizer -BioNtech) and BBIBP-CorV (Sinopharm) vaccines.MethodsWe conducted a cross-sectional study analyzing the titers of the serum agglutinins (S. typhi O and H antigen, and S. paratyphi A and B antigen) in 50 adults.ResultsThe proportion of false positives for O, H, A, and B antigens was 60, 44, 8, and 40%, respectively (total false positives = 38%). …”
Get full text

COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis by Angel Justiz-Vaillant, Kimberly Roopnarine, Shaundell Solomon, Alyssa Phillips, Solange Sandy, Alyssa Subero, Sarah Seepersad, Nicholas Span, Phalmanie Ramnath, Akaasha Ramnarine, Bimala Ramdath, Chelsea Rampaul, Renissa Ramdial, Dana Phagoo, Thalia Ramdhanie, Vinaya Moonilal, Emily-Marie Poliah, Steffan Poonwassie, Karishta Punilal, Sarah Panchoo, Justice Parris, Steven Oudit, Trudy Muir, Johnson Nicholas-Joseph, Bijey Raj Pandit, Sanjeev Pakeerah, Vesham Sookoo, Patrice Richards, Tishia John, Darren Gopaul, Sachin Soodeen, Odette Arozarena-Barbosa, Arlene Williams, Chandrashehkar Unakal, Rodolfo Arozarena Fundora, Reinand Thompson, Patrick Eberechi Akpaka

Subjects: “…Pfizer-BioNTech…”
Get full text

Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination by Emilie C. Collins, Michael J. Carr, James Soo Kim, John Lewis Jr., Noble Maleque, Krisha Desai, Lauren Chen, Jon Sevransky, Manila Gaddh, Nadine Rouphael, Jacqueline Hubbard, Andrew M. Pendley

“…We report 2 cases of ITP in healthy 20‐year‐old and 21‐year‐old women presenting to Emory University in Atlanta, GA, 2 days after the second dose and 11 days after the first dose (respectively) of the Pfizer‐BioNTech messenger RNA severe acute respiratory syndrome coronavirus 2 vaccine. …”
Get full text

COVID-19 Vaccination Protects Skeletal Muscle Against Statin-Related Side Effects by Daria Schetz, Jacek Sein Anand, Karolina Kuźbicka, Marcin Wirtwein, Ivan Kocić

Subjects: Get full text

Safety and Immunogenicity of Pfizer BioNTech mRNA Vaccine and Novavax NVX-CoV2373 COVID-19 Mix and Match Booster Vaccination in Adolescents Aged 12-17 Years with HIV infection in Kenya by Dr Lucas Tina, Dr Amos Ndhere

“…Adolescents who received homologous MoH primary vaccination platform with mRNA COVID-19 vaccines, were randomized 1:1 to receive a homologous or heterologous single booster dose of either Pfizer BioNTech mRNA COVID-19 Vaccine or Novavax NVX-CoV2373 Protein Sub-Unit COVID-19 vaccine. …”
Get full text

Effectiveness of the Pfizer-BioNTech (BNT162b2) vaccine against the omicron variant of SARS-CoV-2 among adults aged 50 and above: A case-control study in Lebanon, June 2022. by Maryo Baakliny, Nada Ghosn, Nadine Saleh, Patrick Maison

“…The findings of this study highlight the effectiveness of the Pfizer-BioNTech (BNT162b2) vaccine in reducing the odds of symptomatic COVID-19, particularly by decreasing the prevalence of key symptoms such as fever, cough, myalgia, and loss of taste or smell. …”
Get full text

COVID-19 vaccination-related attendance at a pediatric emergency department in Singapore among 12- to 18-year old adolescents by Nicholas Beng Hui Ng, Gayle Fleur Appleby, Xin Yi Thong, Sze Kiat Alan Ong, Stephanie Zhen Wan Hii, Ian Kai Zhi Tan, Sharad Mohite, Pao Tang Kao

Subjects: Get full text